Differentiated cultures of an immortalized human neural progenitor cell line do not replicate prions despite PrP^C overexpression

References

• Ritchie DL, Ironside JW. Neuropathology of human prion diseases. Prog Mol Biol Transl Sci. 2017;150:319–339.
   PubMed Web of Science ®Google Scholar
• Orge L, Lima C, Machado C, et al. Neuropathology of animal prion diseases. Biomolecules. 2021;11(3):466. DOI:10.3390/biom11030466
   PubMed Web of Science ®Google Scholar
• Prusiner SB. Prions. Proc Natl Acad Sci U S A. 1998;95(23):13363–13383.
   PubMed Web of Science ®Google Scholar
• Marín-Moreno A, Fernández-Borges N, Espinosa JC, et al. Transmission and replication of prions. Prog Mol Biol Transl Sci. 2017;150:181–201.
   PubMed Web of Science ®Google Scholar
• Block AJ, Bartz JC. Prion strains: shining new light on old concepts. Cell Tissue Res. 2022;392(1):113–133.
   PubMed Web of Science ®Google Scholar
• Igel-Egalon A, Béringue V, Rezaei H, et al. Prion strains and transmission barrier phenomena. Pathogens. 2018;7(1):5. DOI:10.3390/pathogens7010005
   PubMed Web of Science ®Google Scholar
• Watts JC, Prusiner SB. Mouse models for studying the formation and propagation of prions. J Biol Chem. 2014;289(29):19841–19849.
   PubMed Web of Science ®Google Scholar
• Marín-Moreno A, Espinosa JC, Torres JM. Transgenic mouse models for the study of prion diseases. Prog Mol Biol Transl Sci. 2020;175:147–177.
   PubMed Web of Science ®Google Scholar
• Arshad H, Bourkas MEC, Watts JC. The utility of bank voles for studying prion disease. Prog Mol Biol Transl Sci. 2020;175:179–211.
   PubMed Web of Science ®Google Scholar
• Arshad H, Watts JC. Genetically engineered cellular models of prion propagation. Cell Tissue Res. 2022;392(1):63–80.
   PubMed Web of Science ®Google Scholar
• Priola SA. Cell biology approaches to studying prion diseases. Methods Mol Biol. 2017;1658:83–94.
   PubMedGoogle Scholar
• Vorberg I, Chiesa R. Experimental models to study prion disease pathogenesis and identify potential therapeutic compounds. Curr Opin Pharmacol. 2019;44:28–38.
   PubMed Web of Science ®Google Scholar
• Islam AM T, Adlard PA, Finkelstein DI, et al. Acute neurotoxicity models of prion disease. ACS Chem Neurosci. 2018;9(3):431–445. DOI:10.1021/acschemneuro.7b00517
   PubMed Web of Science ®Google Scholar
• Pineau H, Sim V. Poscabilities: the application of the prion organotypic slice culture assay to neurodegenerative disease research. Biomolecules. 2020;10(7):1079.
   PubMed Web of Science ®Google Scholar
• Falsig J, Julius C, Margalith I, et al. A versatile prion replication assay in organotypic brain slices. Nat Neurosci. 2008;11(1):109–117. DOI:10.1038/nn2028
   PubMed Web of Science ®Google Scholar
• Falsig J, Sonati T, Herrmann US, et al. Prion pathogenesis is faithfully reproduced in cerebellar organotypic slice cultures. PLOS Pathog. 2012;8(11):e1002985. DOI:10.1371/journal.ppat.1002985
   PubMed Web of Science ®Google Scholar
• Giri RK, Young R, Pitstick R, et al. Prion infection of mouse neurospheres. Proc Natl Acad Sci U S A. 2006;103(10):3875–3880. DOI:10.1073/pnas.0510902103
   PubMed Web of Science ®Google Scholar
• Milhavet O, Casanova D, Chevallier N, et al. Neural stem cell model for prion propagation. Stem Cells. 2006;24(10):2284–2291. DOI:10.1634/stemcells.2006-0088
   PubMed Web of Science ®Google Scholar
• Herva ME, Relaño-Ginés A, Villa A, et al. Prion infection of differentiated neurospheres. J Neurosci Methods. 2010;188(2):270–275. DOI:10.1016/j.jneumeth.2010.02.022
   PubMed Web of Science ®Google Scholar
• Iwamaru Y, Takenouchi T, Imamura M, et al. Prion replication elicits cytopathic changes in differentiated neurosphere cultures. J Virol. 2013;87(15):8745–8755. DOI:10.1128/JVI.00572-13
   PubMed Web of Science ®Google Scholar
• Relaño-Ginès A, Gabelle A, Hamela C, et al. Prion replication occurs in endogenous adult neural stem cells and alters their neuronal fate: involvement of endogenous neural stem cells in prion diseases. PLOS Pathog. 2013;9(8):e1003485. DOI:10.1371/journal.ppat.1003485
   PubMed Web of Science ®Google Scholar
• Pradines E, Hernandez-Rapp J, Villa-Diaz A, et al. Pathogenic prions deviate PrPC signaling in neuronal cells and impair A-beta clearance. Cell Death Dis. 2013;4(1):e456. DOI:10.1038/cddis.2012.195
   PubMedGoogle Scholar
• Collins SJ, Haigh CL. Simplified murine 3D neuronal cultures for investigating neuronal activity and neurodegeneration. Cell Biochem Biophys. 2017;75(1):3–13.
   PubMed Web of Science ®Google Scholar
• Iwamaru Y, Mathiason CK, Telling GC, et al. Chronic wasting disease prion infection of differentiated neurospheres. Prion. 2017;11(4):277–283. DOI:10.1080/19336896.2017.1336273
   PubMed Web of Science ®Google Scholar
• Choi SH, Kim YH, Hebisch M, et al. A three-dimensional human neural cell culture model of Alzheimer’s disease. Nature. 2014;515(7526):274–278. DOI:10.1038/nature13800
   PubMed Web of Science ®Google Scholar
• D’Avanzo C, Sliwinski C, Wagner SL, et al. γ-Secretase modulators reduce endogenous amyloid β42 levels in human neural progenitor cells without altering neuronal differentiation. Faseb J. 2015;29(8):3335–3341. DOI:10.1096/fj.15-271015
   PubMed Web of Science ®Google Scholar
• Kim YH, Choi SH, D’Avanzo C, et al. A 3D human neural cell culture system for modeling Alzheimer’s disease. Nat Protoc. 2015;10(7):985–1006. DOI:10.1038/nprot.2015.065
   PubMed Web of Science ®Google Scholar
• Jorfi M, D’Avanzo C, Tanzi RE, et al. Human neurospheroid arrays for in vitro studies of alzheimer’s disease. Sci Rep. 2018;8(1):2450. DOI:10.1038/s41598-018-20436-8
   PubMedGoogle Scholar
• Donato R, Miljan EA, Hines SJ, et al. Differential development of neuronal physiological responsiveness in two human neural stem cell lines. BMC Neurosci. 2007;8(1):36. DOI:10.1186/1471-2202-8-36
   PubMedGoogle Scholar
• Pai S, Verrier F, Sun H, et al. Dynamic mass redistribution assay decodes differentiation of a neural progenitor stem cell. J Biomol Screen. 2012;17(9):1180–1191. DOI:10.1177/1087057112455059
   PubMedGoogle Scholar
• Song Y, Subramanian K, Berberich MJ, et al. A dynamic view of the proteomic landscape during differentiation of ReNcell VM cells, an immortalized human neural progenitor line. Sci Data. 2019;6(1):190016. DOI:10.1038/sdata.2019.16
   PubMedGoogle Scholar
• J-H O, Jung C-R, Lee M-O, et al. Comparative analysis of human embryonic stem cell-derived neural stem cells as an in vitro human model. Int J Mol Med. 2018;41:783–790.
   PubMed Web of Science ®Google Scholar
• Wan X, Wu X, Hill MA, et al. ReN VM spheroids in matrix: a neural progenitor three-dimensional in vitro model reveals DYRK1A inhibitors as potential regulators of radio-sensitivity. Biochem Biophys Res Commun. 2020;531(4):535–542. DOI:10.1016/j.bbrc.2020.07.130
   PubMed Web of Science ®Google Scholar
• Nierode GJ, Gopal S, Kwon P, et al. High-throughput identification of factors promoting neuronal differentiation of human neural progenitor cells in microscale 3D cell culture. Biotechnol Bioeng. 2019;116(1):168–180. DOI:10.1002/bit.26839
   PubMed Web of Science ®Google Scholar
• Allison WT. The intrigue is infectious: impacts of prion protein during neural development. Dev Biol. 2018;441(1):1–3.
   PubMed Web of Science ®Google Scholar
• Martin D, Reine F, Herzog L, et al. Prion potentiation after life-long dormancy in mice devoid of PrP. Brain Commun. 2021;3(2):fcab092. DOI:10.1093/braincomms/fcab092
   PubMedGoogle Scholar
• Atkinson PH. Glycosylation of prion strains in transmissible spongiform encephalopathies. Aust Vet J. 2004;82(5):292–299.
   PubMed Web of Science ®Google Scholar
• Kang H-E, Bian J, Kane SJ, et al. Incomplete glycosylation during prion infection unmasks a prion protein epitope that facilitates prion detection and strain discrimination. J Biol Chem. 2020;295(30):10420–10433. DOI:10.1074/jbc.RA120.012796
   PubMed Web of Science ®Google Scholar
• Tuzi NL, Cancellotti E, Baybutt H, et al. Host PrP glycosylation: a major factor determining the outcome of prion infection. PLoS Biol. 2008;6(4):e100. DOI:10.1371/journal.pbio.0060100
   PubMed Web of Science ®Google Scholar
• Burke CM, Walsh DJ, Mark KMK, et al. Cofactor and glycosylation preferences for in vitro prion conversion are predominantly determined by strain conformation. PLOS Pathog. 2020;16(4):e1008495. DOI:10.1371/journal.ppat.1008495
   PubMed Web of Science ®Google Scholar
• Camacho MV, Telling G, Kong Q, et al. Role of prion protein glycosylation in replication of human prions by protein misfolding cyclic amplification. Lab Invest. 2019;99(11):1741–1748. DOI:10.1038/s41374-019-0282-1
   PubMed Web of Science ®Google Scholar
• C-W Y, Wang L-Q, Huang J-J, et al. Glycosylation significantly inhibits the aggregation of human prion protein and decreases its cytotoxicity. Sci Rep. 2018;8(1):12603. DOI:10.1038/s41598-018-30770-6
   PubMedGoogle Scholar
• Sevillano AM, Aguilar-Calvo P, Kurt TD, et al. Prion protein glycans reduce intracerebral fibril formation and spongiosis in prion disease. J Clin Invest. 2020;130(3):1350–1362. DOI:10.1172/JCI131564
   PubMed Web of Science ®Google Scholar
• Salamat MK, Dron M, Chapuis J, et al. Prion propagation in cells expressing PrP glycosylation mutants. J Virol. 2011;85(7):3077–3085. DOI:10.1128/JVI.02257-10
   PubMed Web of Science ®Google Scholar
• Marshall KE, Hughson A, Vascellari S, et al. PrP knockout cells expressing transmembrane PrP resist prion infection. J Virol. 2017;91(2):e01686. DOI:10.1128/JVI.01686-16
   PubMed Web of Science ®Google Scholar
• Klingeborn M, Race B, Meade-White KD, et al. Crucial role for prion protein membrane anchoring in the neuroinvasion and neural spread of prion infection. J Virol. 2011;85(4):1484–1494. DOI:10.1128/JVI.02167-10
   PubMed Web of Science ®Google Scholar
• Puig B, Altmeppen HC, Linsenmeier L, et al. GPI-anchor signal sequence influences PrPC sorting, shedding and signalling, and impacts on different pathomechanistic aspects of prion disease in mice. PLOS Pathog. 2019;15(1):e1007520. DOI:10.1371/journal.ppat.1007520
   PubMed Web of Science ®Google Scholar
• Arshad H, Patel Z, Mehrabian M, et al. The aminoglycoside G418 hinders de novo prion infection in cultured cells. J Biol Chem. 2021;297(3):101073. DOI:10.1016/j.jbc.2021.101073
   PubMed Web of Science ®Google Scholar
• Forloni G, Iussich S, Awan T, et al. Tetracyclines affect prion infectivity. Proc Natl Acad Sci U S A. 2002;99(16):10849–10854. DOI:10.1073/pnas.162195499
   PubMed Web of Science ®Google Scholar
• Adjou KT, Deslys JP, Demaimay R, et al. Probing the dynamics of prion diseases with amphotericin B. Trends Microbiol. 1997;5(1):27–31. DOI:10.1016/S0966-842X(97)81771-4
   PubMed Web of Science ®Google Scholar
• Demaimay R, Race R, Chesebro B. Effectiveness of polyene antibiotics in treatment of transmissible spongiform encephalopathy in transgenic mice expressing Syrian hamster PrP only in neurons. J Virol. 1999;73(4):3511–3513.
   PubMed Web of Science ®Google Scholar
• Adjou KT, Privat N, Demart S, et al. MS-8209, an amphotericin B analogue, delays the appearance of spongiosis, astrogliosis and PrPres accumulation in the brain of scrapie-infected hamsters. J Comput Pathol. 2000;122(1):3–8. DOI:10.1053/jcpa.1999.0338
   PubMed Web of Science ®Google Scholar
• Mangé A, Nishida N, Milhavet O, et al. Amphotericin B inhibits the generation of the scrapie isoform of the prion protein in infected cultures. J Virol. 2000;74(7):3135–3140. DOI:10.1128/JVI.74.7.3135-3140.2000
   PubMed Web of Science ®Google Scholar
• Soler L, Caffrey P, McMahon HEM. Effects of new amphotericin analogues on the scrapie isoform of the prion protein. Biochim Biophys Acta. 2008;1780(10):1162–1167.
   PubMed Web of Science ®Google Scholar
• Marbiah MM, Harvey A, West BT, et al. Identification of a gene regulatory network associated with prion replication. Embo J. 2014;33(14):1527–1547. DOI:10.15252/embj.201387150
   PubMed Web of Science ®Google Scholar
• Krejciova Z, Alibhai J, Zhao C, et al. Human stem cell–derived astrocytes replicate human prions in a PRNP genotype–dependent manner. J Exp Med. 2017;214(12):3481–3495. DOI:10.1084/jem.20161547
   PubMed Web of Science ®Google Scholar
• Groveman BR, Foliaki ST, Orru CD, et al. Sporadic Creutzfeldt-Jakob disease prion infection of human cerebral organoids. Acta Neuropathol Commun. 2019;7(1):12. DOI:10.1186/s40478-019-0742-2
   PubMed Web of Science ®Google Scholar
• Imamura M, Tabeta N, Kato N, et al. Heparan sulfate and heparin promote faithful prion replication in vitro by binding to normal and abnormal prion proteins in protein misfolding cyclic amplification *. J Biol Chem. 2016;291(51):26478–26486. DOI:10.1074/jbc.M116.745851
   PubMed Web of Science ®Google Scholar
• Orrù CD, Groveman BR, Hughson AG, et al. RT-Quic assays for prion disease detection and diagnostics. Methods Mol Biol. 2017;1658:185–203.
   PubMedGoogle Scholar